Related Experiment Video
Updated: May 15, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Invasive aspergillosis in children and adolescents
Andreas H Groll1, Dominik Schrey, Athanasios Tragiannidis
1Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology, University Children's Hospital, Muenster, Germany. grollan@ukmuenster.de
Insights
Invasive aspergillosis in immunocompromised children presents unique challenges. This review covers diagnosis, treatment, and prevention strategies specific to pediatric patients.
Area of Science:
- Pediatric Infectious Diseases
- Mycology
- Immunocompromised Host
Background:
- Invasive aspergillosis is a significant cause of illness and death in immunocompromised children.
- Effective disease control requires a multi-faceted approach including prevention, early diagnosis, and treatment.
- Pediatric invasive aspergillosis differs from adult forms in presentation, epidemiology, diagnostics, and antifungal pharmacokinetics.
Purpose of the Study:
- To review the clinical presentation and epidemiology of invasive aspergillosis in children and adolescents.
- To discuss the utility of current diagnostic tools and strategies for this population.
- To explore treatment and prevention options tailored for pediatric patients.
Main Methods:
- Literature review focusing on invasive aspergillosis in pediatric populations.
- Analysis of clinical presentation and epidemiological data.
- Evaluation of diagnostic tools, treatment modalities, and preventive measures.
Main Results:
- Invasive aspergillosis in children and adolescents has distinct clinical and epidemiological features compared to adults.
- Newer diagnostic tools and antifungal pharmacokinetics offer unique considerations for pediatric care.
- A comprehensive strategy is essential for managing this infection in immunocompromised youth.
Conclusions:
- Understanding the unique aspects of invasive aspergillosis in children is crucial for effective management.
- Optimizing diagnostic and therapeutic approaches is vital for improving outcomes.
- Further research into pediatric-specific strategies for prevention and treatment is warranted.
Abstract:
Invasive aspergillosis is an important cause of morbidity and mortality in immunocompromised children. Disease control depends on prevention, early diagnosis, predictive microbiological information, prompt and appropriate treatment and restoration of host defenses. Relative to adults, invasive aspergillosis in children and adolescents is unique in its clinical presentation, epidemiology, and in particular, the utility of newer diagnostic tools and the pharmacokinetics of active antifungal agents. Here we review the presentation and epidemiology of invasive aspergillosis in children and adolescents and discuss the value of current diagnostic tools and strategies and options for treatment and prevention in this special population.
Related Concept Videos
Fungal Phylum Ascomycota
Atypical Pneumonia
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Antifungal Agents
Bacterial Meningitis I: Introduction
Fungal Phylum Microsporidia
